Hospira Reports First-Quarter 20...( Diluted ...),Health

Date:4/28/2009

====== ====== Diluted 160.6 161.0 (0.2)% ====== ====== Adjusted Gross Profit (1)(2) $339.6 $337.5 0.6 % Adjusted Income From Operations (1) $149.9 $145.2 3.2 % Adjusted Net Income (1) $96.8 $87.9 10.1 % Adjusted Diluted Earnings Per Share (1) $0.60 $0.55 9.1 % Statistics (as a % of net sales, except for income tax rate): Three Months Ended Three Months Ended March 31, 2009 March 31, 2008 ---------------------- ---------------------- GAAP Adjusted (1) GAAP Adjusted (1) ------ ------------ ------ ------------ Gross Profit (2) 37.2 % 39.5 % 35.7 % 38.0 % Income From Operations 13.3 % 17.4 % 12.6 % 16.3 % Net Income 19.3 % 11.3 % 7.4 % 9.9 % Income Tax Rate (87.8)% 21.5 % 22.5 % 25.5 % (1) The Non-GAAP financial measures contained in this press release (gross profit, income from operations, net income, and diluted Earnings Per Share) adjust for items that are unusual or nonrecurring. Unusual or nonrecurring items can be highly variable, difficult to predict, and of a size that may substantially impact Hospira's reported results for a period. Management believes that Non-GAAP financial measures can facilitate a complete analysis of Hospira's results of operations, particularly in evaluating performance over time. Management uses these Non-GAAP financial measures internally in financial planning, to monitor business unit performance, and in evaluating managem
'/>"/>

SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. Hospira to Host Conference Call for First-Quarter 2009 Results
2. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
3. Hospira Expands Board of Directors
4. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
5. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
6. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
7. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
8. Hospira Names Ken Meyers to Lead Human Resources
9. Hospira Reports Third-Quarter 2008 Results
10. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
11. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection